NCT05854277

Brief Summary

CCIS is a novel score, created specifically to evaluate the completeness of caecal visualized. It can be applied to a single or multiple images. To create the CCIS, the caecum was divided into eight parts: the appendiceal orifice (AO), the tri-radiate fold part 1 (TF-1), 2 (TF-2), 3 (TF-3) and four outer quadrants (OQ 1-4). The ileo-caecal valve (ICV) is a reference point but is not part of the score. The quadrant adjacent to the ICV is labelled OQ1. The three other quadrants are labelled clockwise from this quadrant. The tri-radiate folds are also labelled clockwise with TF1 representing the triangle side that is majority-contained within OQ1. TF2 and TF3 are then labelled clockwise from TF1.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 15, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 11, 2023

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

14 days

First QC Date

March 15, 2023

Last Update Submit

May 2, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • VALIDATE A NOVEL SCORE FOR THE COMPLETENESS OF CAECAL INTUBATION

    To create the CCIS, the caecum is divided into eight parts: the appendiceal orifice (AO), the tri-radiate fold part 1 (TF-1), 2 (TF-2), 3 (TF-3) and four outer quadrants (OQ 1-4). The ileo-cacecal valve (ICV) is a reference point but is not part of the score. The quadrant adjacent to the valve is labelled OQ1. The three other quadrants are labelled clockwise from this quadrant. For every component of the CCIS that is completely visualized on the image, one point is gained with a maximum possible CCIS of 8 and a minimum of 0. Participants were asked to answer the same six questions for each image-set. * Is this an image of the caecum? * What is the Boston Bowel Preparation score for this segment of the colon? * What is your subjective first impression (yes/no) regarding completeness of caecal intubation? * What subjective percentage do you believe was assessed? * What is the CCIS score for this image-set? * Using the online tool, which components of the CCIS were seen

    4 weeks

Study Arms (1)

Endoscopists

OTHER
Other: educational video

Interventions

To explain the novel score, a six-minute instructional video was compiled and available to watch, as well as an online tool on the GIEQs website that could be used to grade the image-sets using the score.

Endoscopists

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Endoscopists \>18 years old

You may not qualify if:

  • Endoscopist not signing informed consent
  • Any other medical doctor not connected with endoscopic practice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Gent

Ghent, 9000, Belgium

Location

MeSH Terms

Conditions

Colonic PolypsColorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2023

First Posted

May 11, 2023

Study Start

February 1, 2021

Primary Completion

February 15, 2021

Study Completion

February 28, 2021

Last Updated

May 11, 2023

Record last verified: 2023-05

Locations